Showing results (111-120 of 239) with videos related to
Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IXOtto Metzger-Filho, Zhuoxin Sun, Giuseppe Viale, et al.Breast (Edinburgh, Scotland)|November 26, 2025
Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 9)Alexandru Eniu, Runcie C W Chidebe, Peter Vuylsteke, et al.Therapeutic Advances in Medical Oncology|March 2, 2023
Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2- advanced breast cancer: a matching-adjusted indirect comparisonHope S Rugo, Victoria Harmer, Joyce O'Shaughnessy, et al.Investigational New Drugs|August 4, 2010
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignanciesElisabeth I Heath, Patricia Lorusso, Suresh S Ramalingam, et al.BMC Genomics|June 8, 2007
Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic toolsRobert A Ach, Arno Floore, Bo Curry, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.Anticancer Research|August 15, 2002
3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot studyAntonio Fabiano Ferreira Filho, John Crown, Fatima Cardoso, et al.Breast (Edinburgh, Scotland)|November 26, 2025
Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (goal 3)Karen Gelmon, Cynthia Villarreal-Garza, Dawn Aubel, et al.Journal of the National Cancer Institute|July 13, 2026
Recurrence risk in HR-positive/HER2-negative early breast cancer: real-world US electronic health records studyPaolo Tarantino, Giuseppe Curigliano, Erika Hamilton, et al.ESMO Open|May 23, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast CancerEvandro de Azambuja, Dario Trapani, Sibylle Loibl, et al.Pageof 24